1. Market Research
  2. > Pharmaceutical Market Trends
  3. > World Generic Markets 04 JANUARY 2016

World Generic Markets 04 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 32 pages

Industry Trend Analysis - Acquisition Battles Dominated Generic Industry In 2015 And Will Shape It In 2016
Industry Trend Analysis - Argentinean Acquisition Positions Stada For Latin America Expansion
Industry Trend Analysis - Merger Highlights Ongoing Consolidation Trend In Generics
Industry Brief - Amneal Launches Lidocaine Ointment
Industry Brief - Teligent Gains US Cefotetan Approval
Industry Brief - Generic Oseltamivir Litigation Settled
Industry Brief - Rising Launches Olopatadine Ophthalmic Solution
Industry Brief - Heritage Launches Verapamil In US
Industry Trend Analysis - US Biosimilar Market Set To Take Off In 2016
Industry Brief - Unichem Gains FDA Irbesartan Approval
Industry Brief - Antares Gains FDA Sumatriptan Approval
Industry Brief - ANI Gains Polyethylene Glycol 3350 Approval
Industry Brief - Endo Gains Diclofenac Gel Rights Extension
Industry Brief - Celgene Settles Lenalidomide Patent Litigation
Industry Brief - VistaPharm Launches Potassium Chloride
Industry Brief - Perrigo Acquires Tretinoin Portfolio
Industry Brief - Sun Gains US Imatinib Approval
Industry Brief - TWi Gains Megestrol Appellate Court Victory
Industry Brief - Alcohol-Free Docetaxel Approved By FDA
Industry Brief - ANI Launches Nimodipine, Flecainide
Industry Brief - Mylan Launches Linezolid Tablets
Industry Brief - Dr Reddy's Re-launches Esomeprazole Capsules
Industry Brief - Vertice Completes VistaPharm Acquisition
Industry Brief - Aurobindo Gains Olopatadine, Famotidine Approvals
Industry Brief - Glenmark Gains Linezolid Approval
Industry Trend Analysis - BsUFA Reauthorisation Meeting Highlights Shortfalls In US Biosimilar Programme
Industry Brief - Lupin Gains Potassium Chloride Approval
Industry Brief - Hikma Gains FDA Neostigmine Approval
Industry Brief - Allergan/Perrigo Launch OTC Guaifenesin
Industry Trend Analysis - Generic Drug Pricing Will Be Subject Of Scrutiny In 2016
Industry Brief - Amgen Submits Biosimilar Adalimumab MAA To EMA
Industry Brief - EMA Accepts Sandoz' Etanercept Submission
Industry Brief - EMA Commences Evaluation Of Gedeon Richter's Pegfilgrastim
Industry Brief - Navamedic Expands Aspen Agreement
Industry Trend Analysis - Resolution Positions Stada To Capitalise On Serbian Sales Growth
Industry Trend Analysis - Western Europe Poised To Become Krka's Most Important Region
Industry Brief - Eisai Completes Liaoning TianYi Biological Pharmaceutical Acquisition
Industry Brief - Cipla, Biocon And Strides Shasun Launch Sofosbuvir Products
Industry Brief - Daiichi Sankyo Launches New Generic Drugs In Japan
Industry Brief - Takeda/Teva Business Venture Takes Shape
Industry Brief - MPP/AbbVie Sign ARV Licensing Deal For Africa

Table Of Contents

World Generic Markets 04 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.